2[1]Febbraio M,Hajjar DP,Silverstein RL.CD36:a class B scavenger receptor involved in angioigenesis,atherosclerosis,inflammation,and lipid metabolism.J Clin Invest,2001,108:785-791.
3[2]Nakata A,Nakagawa Y,Nishida M,et al.CD36,a novel receptor for oxidized low-density lipoproteins,is highly expressed on lipid-laden macrophages in human atherosclerosis aorta.Arterioscler Thromb Vasc Biol,1999,19:1333-1339.
4[3]Raja SG,Dreyfus GD.Statins:much more than just a lipidlowering therapy.Indian Heart J,2004,56:204-209.
5[4]McLouphlin C.Statins.Prof Nurse,2004,19:51-2.
6[5]Shukla A,Sharma MK,Jain A,et al.Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients-a controlled randomized trial.Indian Heart J,2005,57:675-680.
7[6]Lin R,Liu J,Peng N,et al.Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells.Biol Pharm Bull,2005,28:1630-1634.
8[7]Aikawa M,Rabkin E,Okada Y,et al.Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma:a potential mechanism of lesion stabilization.Circulation,1998,97:2433-2444.
9[8]Haendeler J,Hoffmann J,Zeiher AM,et al.Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial.Cells,2004,110:856-861.
10[9]Umetani N,Kanayama Y,Okamura M,et al.Lovastatin inhibits gene expression of type-Ⅰ scavenger receptor in THP-1 hunan macrophages.Biochim Biophys Acta,1996,1303:199-206.
